CR20140490A - Uso intrauterino de 18-metil-15b, 16b-metilen-19-nor-20-espirox-4-en-3-onas, sistemas intrauterinos que contienen 18-metil-15b, 16b-metilen-19-nor-20-espirox-4-en-3-onas, asi como su uso en la anticoncepcion y terapia - Google Patents

Uso intrauterino de 18-metil-15b, 16b-metilen-19-nor-20-espirox-4-en-3-onas, sistemas intrauterinos que contienen 18-metil-15b, 16b-metilen-19-nor-20-espirox-4-en-3-onas, asi como su uso en la anticoncepcion y terapia

Info

Publication number
CR20140490A
CR20140490A CR20140490A CR20140490A CR20140490A CR 20140490 A CR20140490 A CR 20140490A CR 20140490 A CR20140490 A CR 20140490A CR 20140490 A CR20140490 A CR 20140490A CR 20140490 A CR20140490 A CR 20140490A
Authority
CR
Costa Rica
Prior art keywords
espirox
metilen
onas
intrauterine
methyl
Prior art date
Application number
CR20140490A
Other languages
English (en)
Inventor
Norbert Schmees
Lars Röse
Tuula Valo
Katja Prelle
Reinhard Nubbemeyer
Henriikka Korolainen
Harri Jukarainen
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48142002&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR20140490(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of CR20140490A publication Critical patent/CR20140490A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención describe el uso intrauterinode 18-metil-15ß,16ß-metilen-19-nor-20-espirox-4-en-3-onasde la fórmula general (1)en la anticoncepción la terapia ginecológica, así como un sistema intrauterino que contiene compuestos de la fórmula 1.
CR20140490A 2012-04-23 2014-10-23 Uso intrauterino de 18-metil-15b, 16b-metilen-19-nor-20-espirox-4-en-3-onas, sistemas intrauterinos que contienen 18-metil-15b, 16b-metilen-19-nor-20-espirox-4-en-3-onas, asi como su uso en la anticoncepcion y terapia CR20140490A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102012206652 2012-04-23
PCT/EP2013/058220 WO2013160213A1 (de) 2012-04-23 2013-04-19 INTRAUTERINE ANWENDUNG VON 18-METHYL-15ß,16ß-METHYLEN-19-NOR-20-SPIROX-4-EN-3-ONEN, INTRAUTERINE SYSTEME ENTHALTEND 18-METHYL-15ß,16ß-METHYLEN-19-NOR-20-SPIROX-4-EN-3-ONE, SOWIE DEREN VERWENDUNG IN DER KONTRAZEPTION UND GYNÄKOLOGISCHEN THERAPIE

Publications (1)

Publication Number Publication Date
CR20140490A true CR20140490A (es) 2014-11-17

Family

ID=48142002

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20140490A CR20140490A (es) 2012-04-23 2014-10-23 Uso intrauterino de 18-metil-15b, 16b-metilen-19-nor-20-espirox-4-en-3-onas, sistemas intrauterinos que contienen 18-metil-15b, 16b-metilen-19-nor-20-espirox-4-en-3-onas, asi como su uso en la anticoncepcion y terapia

Country Status (28)

Country Link
US (1) US20150065472A1 (es)
EP (1) EP2841074A1 (es)
JP (1) JP2015514791A (es)
KR (1) KR20150004807A (es)
CN (1) CN104254333A (es)
AR (1) AR090799A1 (es)
AU (1) AU2013254840A1 (es)
BR (1) BR112014026193A2 (es)
CA (1) CA2871003A1 (es)
CL (1) CL2014002836A1 (es)
CO (1) CO7111255A2 (es)
CR (1) CR20140490A (es)
CU (1) CU20140121A7 (es)
DO (1) DOP2014000241A (es)
EA (1) EA201491922A1 (es)
EC (1) ECSP14024250A (es)
HK (1) HK1205000A1 (es)
IL (1) IL235095A0 (es)
IN (1) IN2014DN07839A (es)
MA (1) MA37444A1 (es)
MX (1) MX2014012849A (es)
PE (1) PE20142438A1 (es)
PH (1) PH12014502372A1 (es)
SG (1) SG11201406582XA (es)
TN (1) TN2014000444A1 (es)
TW (1) TW201350122A (es)
UY (1) UY34758A (es)
WO (1) WO2013160213A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015055789A1 (en) * 2013-10-17 2015-04-23 Bayer Pharma Aktiengesellschaft INTRAVAGINAL USE OF 18-METHYL-15ß,16ß-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONES, INTRAVAGINAL RINGS COMPRISING 18-METHYL-15ß,16ß-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONES, AND USE THEREOF IN CONTRACEPTION

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI90627C (fi) 1992-07-31 1994-03-10 Leiras Oy Laitteisto lääkeainesauvan varustamiseksi vaipalla
PH30867A (en) 1992-07-31 1997-12-09 Leiras Oy Method and equipment for installing a medicine capsule on a support.
FI107339B (fi) 1998-06-30 2001-07-13 Leiras Oy Lääkeaineiden läpäisynopeutta säätävä kalvo tai matriisi
US6056976A (en) 1998-11-12 2000-05-02 Leiras Oy Elastomer, its preparation and use
PL201878B1 (pl) * 2000-01-18 2009-05-29 Bayer Schering Pharma Ag Kompozycja farmaceutyczna w doustnej postaci dawkowania. zawierająca estrogen i drospirenon, zastosowanie kompozycji i preparat farmaceutyczny
CA2771944A1 (en) * 2003-07-16 2005-01-27 Teva Women's Health, Inc. Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
DE102006030416A1 (de) * 2006-06-29 2008-01-03 Bayer Schering Pharma Ag 18-Methyl-19-nor-androst-4-en-17,17-spiroether (18-Methyl-19-nor-20-spirox-4-en-3-one) sowie diese enthaltende pharmazeutische Präparate
DE102007011105A1 (de) * 2007-03-02 2008-09-04 Bayer Schering Pharma Aktiengesellschaft Mineralcorticoid-Rezeptor-Antagonisten zur Behandlung von Endometriose
DE102007063495A1 (de) * 2007-12-29 2009-09-17 Bayer Schering Pharma Aktiengesellschaft 19-Nor-Steroidderivate mit einer 15α,16α-Methylengruppe und einem gesättigten 17,17-Spirolactonring, deren Verwendung sowie diese Derivate enthaltende Arzneimittel
DE102007063496A1 (de) * 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 15,16-Methylen-17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-on-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
EP2140860A1 (en) * 2008-07-03 2010-01-06 Bayer Schering Pharma Oy An improved method of contraception
PT2012063262W (pt) * 2010-11-08 2015-06-11 Hll Lifecare Ltd Um novo dispositivo intra-uterino com libertação controlada de cobre

Also Published As

Publication number Publication date
AR090799A1 (es) 2014-12-10
EP2841074A1 (de) 2015-03-04
BR112014026193A2 (pt) 2017-06-27
TN2014000444A1 (en) 2016-03-30
WO2013160213A1 (de) 2013-10-31
UY34758A (es) 2013-11-29
PE20142438A1 (es) 2015-02-01
US20150065472A1 (en) 2015-03-05
ECSP14024250A (es) 2015-12-31
HK1205000A1 (en) 2015-12-11
MX2014012849A (es) 2015-02-05
SG11201406582XA (en) 2014-11-27
CL2014002836A1 (es) 2015-03-13
TW201350122A (zh) 2013-12-16
CU20140121A7 (es) 2014-12-26
IL235095A0 (en) 2014-12-31
CN104254333A (zh) 2014-12-31
CO7111255A2 (es) 2014-11-10
MA37444A1 (fr) 2016-11-30
PH12014502372A1 (en) 2015-01-26
KR20150004807A (ko) 2015-01-13
DOP2014000241A (es) 2014-12-31
IN2014DN07839A (es) 2015-04-24
EA201491922A1 (ru) 2015-04-30
CA2871003A1 (en) 2013-10-31
JP2015514791A (ja) 2015-05-21
AU2013254840A1 (en) 2014-11-06

Similar Documents

Publication Publication Date Title
GT201400241A (es) "uso de pro-fungicidas de uk-2a para el control de la sigatoka negra"
CR20150629A (es) Compuestos químicos
UY35943A (es) 5-flúor-4-imino-3-(alquil/alquilo sustituido)-1-(arilsulfonil)-3,4-dihidropirimidin-2(1h)-ona y los procesos para su preparación
UY35500A (es) Indazoles sustituidos con heteroarilo
ECSP11011390A (es) Compuestos espiro-amidas sustituidas
CO6640285A2 (es) 5-alquinil-pirimidinas
UY34632A (es) Compuestos de oxazolidin- 2- ona y usos de los mismos
CR20150247A (es) Anticuerpos de antihemaglutinina y métodos de uso
BR112012032087A2 (pt) composto, medicamento, e, uso de um composto
EA201591196A1 (ru) Композиции и способы для трансдермальной доставки гормонов и других лекарственных средств
BR112015030308A2 (pt) antagonistas de progesterona de imidazolila
UY35129A (es) Compuestos heteroaromáticos y su uso como ligandos d1 de dopamina
DOP2016000089A (es) Sistema de administracion intrauterina
BR112016005972A2 (pt) plataforma semisubmersível equipada com um sistema de amplificação angular
CL2016001024A1 (es) Compuestos derivados de pirido[4,3-b]pirazin-2-carboxamidas; procedimiento de preparacion; composicion farmaceutica y uso para el tratamiento de trastornos neurodegenerativos, esquizofrenia, depresion, entre otras enfermedades.
BR112015024877A2 (pt) vacinas que compreendem polipeptídeos de leishmania para o tratamento e diagnóstico de leishmaniose
CR20140490A (es) Uso intrauterino de 18-metil-15b, 16b-metilen-19-nor-20-espirox-4-en-3-onas, sistemas intrauterinos que contienen 18-metil-15b, 16b-metilen-19-nor-20-espirox-4-en-3-onas, asi como su uso en la anticoncepcion y terapia
CL2015001515A1 (es) Un aparato para humectación y método de uso
CR20140489A (es) Uso de 18-metil-15b, 16b-metilen-19-nor-20-espirox-4-en-3-onas en el tratamiento de menorragia, y sistemas intrauterinos que comprenden 18-metil-15b, 16b-metilen-19-nor-20-espirox-4-en-3-onas para el tratamiento de t
BR102014007923A8 (pt) sistema nanoestruturado polimérico e seu uso
AR098060A1 (es) Sistema de administración intrauterina
UA89388U (ru) Применение глюкозамина гидрохлорида как средства, защищающего организм от системного воздействия высоких температур
ECSP12012115A (es) 5-alquinil-pirimidinas